Skip to content
value.today

Clovis Oncology vs Moderna, Inc.

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • Moderna, Inc. is the larger company by market value: $90.1 B against $302 M for Clovis Oncology, 298 times as much (market caps of Jan 7, 2022 for Clovis Oncology and Oct 30, 2026 for Moderna, Inc.). Clovis Oncology's value is the last on file, from Jan 7, 2022: no market-data feed is connected for its exchange yet.
  • Moderna, Inc. had more revenue: $1.9 B in the year to December 2025 against $149 M for Clovis Oncology in the year to December 2021.
  • Both made a net loss: $265 M for Clovis Oncology and $2.8 B for Moderna, Inc.
  • Moderna, Inc. keeps more of each dollar of sales: a net margin of -145.2% against -177.8% for Clovis Oncology.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

0342685102713702020202120222023202420252026Clovis Oncology 55Moderna, Inc. 1370

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$5B$10B$14B$19B20152016201720182019202020212022202320242025Clovis Oncology $0BModerna, Inc. $2B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureClovis Oncology
CLVS
Moderna, Inc.
MRNA · #275 in the world
Profile
Country🇺🇸 USA🇺🇸 USA
SectorHealthcareHealthcare
IndustryBiotechnologyBiotechnology
Founded20092010
Size
Market cap$302 M*$90.1 B
Revenue$149 M$1.9 B
Net income$-265 M▲ best$-2.8 B
Employees—4,700
Valuation
Price to sales—35.7×
Price to book—10.4×
Free cash flow yield—-2.3%
Profitability
Gross margin—55.4%
Operating margin—-158.1%
Net margin—-145.2%
Return on equity—-28.9%
Growth
Revenue growth—-39.9%
Revenue growth, 3 years a year—-53.4%
Financial strength
Debt to equity—0.1×
Cash
Free cash flow margin—-106.2%
Shareholder returns
Shareholder yield—0.0%
Strength scores
Piotroski F-score—3 of 9
Altman Z-score zone—safe
Data as ofMarket cap Jan 2022Market cap Oct 2026; ratios FY2025

Questions and answers#

Which is bigger, Clovis Oncology or Moderna, Inc.?

Moderna, Inc. is the larger company by market value: $90.1 B against $302 M for Clovis Oncology, 298 times as much (market caps of Jan 7, 2022 for Clovis Oncology and Oct 30, 2026 for Moderna, Inc.). Clovis Oncology's value is the last on file, from Jan 7, 2022: no market-data feed is connected for its exchange yet.

Which makes more money, Clovis Oncology or Moderna, Inc.?

Moderna, Inc. had more revenue: $1.9 B in the year to December 2025 against $149 M for Clovis Oncology in the year to December 2021. Both made a net loss: $265 M for Clovis Oncology and $2.8 B for Moderna, Inc.

Which is more profitable, Clovis Oncology or Moderna, Inc.?

Moderna, Inc. keeps more of each dollar of sales: a net margin of -145.2% against -177.8% for Clovis Oncology.